Sell calls are pretty rare on Wall Street, so when analysts collectively give any name a thumbs down it's probably wise to toss it in the stocks to sell – or at least avoid – pile.
Fortunately, as noted, such stocks are indeed unusual. To get a sense of just how reluctant industry analysts are to issue Sell recommendations, simply take a look at the S&P 500. Only five components of the benchmark index rate a consensus recommendation of Sell, per S&P Global Market Intelligence.
Interestingly, four of these names happen to be members of the S&P 500 Dividend Aristocrats, an index of companies that have increased their dividends annually for at least 25 consecutive years. The Aristocrats are generally considered to be the best dividend stocks for dividend growth, and long-term investors shouldn't dump them automatically just because analysts are negative on them at current levels.
Remember: When an analyst rates a stock at Sell, all that implies is that the equity in question is forecast to underperform the broader market by some margin over the next 12 months or so. Income investors with extended holding periods – we're talking anywhere from five years to decades – needn't worry about such shorter term concerns. The magic of compounding will still redound to truly patient dividend-growth investors.
Here's how we found the five stocks to sell or avoid now. Using data from S&P Global Market Intelligence, we screened the S&P 500 for the stocks with the highest-conviction consensus Sell recommendations by industry analysts.
A note on how the ratings system works: S&P surveys analysts' stock calls and scores them on a five-point scale, where 1.0 equals a Strong Buy and 5.0 is a Strong Sell. Any score higher than 3.5 means that analysts, on average, rate the stock at Sell. The closer a score gets to 5.0, the stronger the consensus Sell recommendation.
After running the screen we were left with the five following names. Although they come from sectors as diverse as consumer staples, financials and utilities, they all have one thing in common: The Street expects them to underperform the broader market over the next year or so.
Market data and analysts' recommendations are as of March 8, courtesy of S&P Global Market Intelligence. Stocks are listed by strength of conviction of analysts' Sell calls, from weakest to strongest.
Clorox
- Market value: $18.7 billion
- Analysts' consensus recommendation: 3.52 (Sell)
Clorox (CLX) stock is off to a strong start in 2023 – up 8.7% vs. 4.3% for the S&P 500 – but analysts don't expect the outperformance to last. That's because the consumer staples stalwart is dealing with both a post-COVID-19 hangover and higher input costs.
"The company had benefited from increased sales during the pandemic as demand for cleansing products spiked," writes Argus Research analyst Taylor Conrad, who rates CLX at Hold. "As benefits from the pandemic have subsided, inflation has put sales and margins under pressure. The company's revenue has fallen from peak pandemic levels, with sequential declines in five of the past eight quarters."
Of the 21 analysts covering this blue chip dividend stock tracked by S&P Global Market Intelligence, one calls it a Strong Buy, one says Buy, nine have it at Hold, six rate it at Sell and four call it a Strong Sell. Their average target price of $141.40 gives Clorox stock implied downside of about 6.5% over the next 12 months or so.
Sponsored Content
Consolidated Edison
- Market value: $32.6 billion
- Analysts' consensus recommendation: 3.56 (Sell)
Founded in 1823, Consolidated Edison (ED) provides electric, gas or steam services to roughly 3.6 million customers in New York City and Westchester County. ConEd also happens to be one of North America's largest solar power providers.
ED stock tends to lag the broader market over pretty much any time frame you care to chart, but it never really underperforms to a disastrous degree, either. Wall Street has never expected much in the way of outperformance, anyway. Indeed, ED has carried a consensus recommendation of Hold or Sell for more than 20 years.
No, ED won't wow investors with its price potential, but few names are more reliable at raising their dividends. This Dividend Aristocrat has hiked its disbursement annually for 49 years.
Ten analysts rate the stock at Hold, three say Sell and three call it a Strong Sell. Their average price target of $88.50 gives ED implied downside of about 4% in the next year.
Sponsored Content
Expeditors International of Washington
- Market value: $17.3 billion
- Analysts' consensus recommendation: 3.59 (Sell)
Global macroeconomics aren't being very kind to transportation and logistics services companies these days, and Expeditors International of Washington (EXPD) has been no exception.
"We expect the current environment of weak demand and significantly lower airfreight and ocean rates to persist in 2023," writes UBS analyst Thomas Wadewitz, who rates EXPD at Sell.
Wadewitz has plenty of company on the Street. Of the 17 analysts covering EXPD tracked by S&P Global Market Intelligence, 11 call it a Hold, two say Sell and four rate it at Strong Sell. That works out to a consensus recommendation of Sell, albeit with moderate conviction. Meanwhile, the Street's average price target of $99.87 gives EXPD stock implied downside of about 11% in the next 12 months or so.
Income investors can at least count on EXPD's regular dividend increases. The company, which pays a semiannual dividend, has hiked the payout annually for almost three decades.
Sponsored Content
Franklin Resources
- Market value: $14.2 billion
- Analysts' consensus recommendation: 3.69 (Sell)
Franklin Resources (BEN), along with its subsidiaries, is best known as Franklin Templeton investments. The global investment firm with $1.5 trillion in assets under management is among the largest in the world.
BEN stock was beating the S&P 500 by about 4 percentage points for the year-to-date through March 8, but the Street doesn't expect the lead to last. Mutual fund providers are under pressure as customers eschew traditional stock pickers in favor of indexed investments. That trend in outflows has much of the Street worried about BEN's prospects.
On the other hand, this Dividend Aristocrat's reliable and generous dividend history should not be overlooked, analysts note.
"While ongoing net asset outflows temper our view, we think the shares are worth holding amid an expected tailwind from an equity market rally and the potential for further industry consolidation," writes CFRA Research analyst Cathy Seifert (Hold).
Seven analysts rate BEN at Hold, while three call it a Sell and three rate it at Strong Sell. Their average price target of $26.92 gives shares implied downside of about 5% in the next year or so.
Sponsored Content
Principal Financial Group
- Market value: $19.6 billion
- Analysts' consensus recommendation: 3.71 (Sell)
No stock in the S&P 500 gets a lower consensus recommendation from Wall Street than Principal Financial Group (PFG).
Of the 14 analysts covering the investment and retirement management firm, one calls it a Strong Buy, five rate it at Hold, four say Sell and four call it a Strong Sell. Although their average target price of $83.08 does give shares implied upside of about 3% in the next 12 months or so, analysts expect PFG's total return to lag that of the broader market.
If PFG is expected to disappoint this year, that's partly due to the fact that it has so overwhelmingly outperformed in the recent past. Shares returned almost 33% over the past 52 weeks vs. a decline of 2.7% for the S&P 500. The trailing three-year annualized return likewise clobbered the broader market, with PFG up 30% vs. 12.1% for the S&P 500.
PFG faces fundamental hurdles as well, such as lower performance fees and higher expenses, notes Credit Suisse analyst Andrew Kligerman, who rates shares at Underweight (the equivalent of Sell).
Sponsored Content
-
AI-Powered Smart Glasses Set to Make a Bigger SplashThe Kiplinger Letter Meta leads the way with its sleek, fashionable smart glasses, but Apple reportedly plans to join the fray by late 2026. Improved AI will lure more customers.
-
How to Plan the Perfect Italian Dream Trip After 60Proper preparation is everything for U.S. retirees when planning an Italy "trip of a lifetime."
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have TodayBerkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
-
If You'd Put $1,000 Into Procter & Gamble Stock 20 Years Ago, Here's What You'd Have TodayProcter & Gamble stock is a dependable dividend grower, but a disappointing long-term holding.
-
I'm an Investing Expert: This Is How You Can Invest Like Warren BuffettBuffett just invested $15 billion in oil and gas, and you can leverage the same strategy in your IRA to potentially generate 8% to 12% quarterly cash flow while taking advantage of tax benefits that are unavailable in any other investment class.
-
7 Essential Investing Rules We All Should KnowThe best time to start investing is right now. That's just one vital rule investors should be familiar with. Here are six more.
-
My Three-Day Rule for Investing: And If it Applies NowStock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Is It Time to Invest in Europe?Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
What Is the Buffett Indicator?"It is better to be roughly right than precisely wrong," writes Carveth Read in "Logic: Deductive and Inductive." That's the premise of the Buffett Indicator.
-
The 24 Cheapest Places To Retire in the USWhen you're trying to balance a fixed income with an enjoyable retirement, cost of living is a crucial factor to consider.
